The Effect of Paclitaxel with a STAT3 Pathway Inhibitor on Metastasis in the Treatment of Triple Negative Breast Cancer

被引：0
|
作者：
Dincsoy, Adnan Berk [1 ]
Gedikli, Esra [1 ]
Ozturk, Suleyman Can [2 ]
Nikshiqi, Erblina [3 ]
Baris, Veysel Ozgur [4 ]
Karakoc, Elif [3 ]
Muftuoglu, Sevda [3 ]
Esendagli, Gunes [5 ]
Erdem, Aysen [1 ]
机构：
[1] Hacettepe Univ, Dept Physiol, Ankara, Turkiye
[2] Hacettepe Univ, Lab Animals Res & Applicat Ctr, Ankara, Turkiye
[3] Hacettepe Univ, Dept Histol & Embryol, Ankara, Turkiye
[4] Dr Ersin Arslan Educ Res Hosp, Gaziantep, Turkiye
[5] Hacettepe Univ, Dept Basic Oncol, Ankara, Turkiye
来源：
ACTA PHYSIOLOGICA | 2023年 / 240卷
关键词：
Triple negative breast cancer; Paclitaxel; STAT3; Stattic; Metastasis;
D O I：
暂无
中图分类号：
Q4 [生理学];
学科分类号：
071003 ;
摘要：
OC-49
引用
收藏
页码：45 / 45
页数：1
相关论文
共 50 条
  • [1] Bt354 as a new STAT3 signaling pathway inhibitor against triple negative breast cancer
    Chen, Yue
    Ji, Ming
    Zhang, Shen
    Xue, Nina
    Xu, Heng
    Lin, Songwen
    Chen, Xiaoguang
    [J]. JOURNAL OF DRUG TARGETING, 2018, 26 (10) : 920 - 930
  • [2] Novel STAT3 inhibitor in the Treatment of Breast Cancer
    Senthil, M.
    Xing, Q.
    Yin, J.
    Buettner, R.
    Horne, D.
    Jove, R.
    Yim, J.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2010, 17 : S50 - S50
  • [3] Genomic regulation of invasion by STAT3 in triple negative breast cancer
    McDaniel, Joy M.
    Varley, Katherine E.
    Gertz, Jason
    Savic, Daniel S.
    Roberts, Brian S.
    Bailey, Sarah K.
    Shevde, Lalita A.
    Ramaker, Ryne C.
    Lasseigne, Brittany N.
    Kirby, Marie K.
    Newberry, Kimberly M.
    Partridge, E. Christopher
    Jones, Angela L.
    Boone, Braden
    Levy, Shawn E.
    Oliver, Patsy G.
    Sexton, Katherine C.
    Grizzle, William E.
    Forero, Andres
    Buchsbaum, Donald J.
    Cooper, Sara J.
    Myers, Richard M.
    [J]. ONCOTARGET, 2017, 8 (05) : 8226 - 8238
  • [4] MYCL promotes the progression of triple-negative breast cancer by activating the JAK/STAT3 pathway
    Jiang, Hongnan
    Li, Xiaojun
    Wang, Wei
    Hu, Yaofeng
    Ren, Dongliang
    [J]. ONCOLOGY REPORTS, 2022, 48 (05)
  • [5] Sanyin Formula Enhances the Therapeutic Efficacy of Paclitaxel in Triple-Negative Breast Cancer Metastases through the JAK/STAT3 Pathway in Mice
    Wu, Chunyu
    Sun, Chenping
    Han, Xianghui
    Ye, Yiyi
    Qin, Yuenong
    Liu, Sheng
    [J]. PHARMACEUTICALS, 2023, 16 (01)
  • [6] Targeting mitochondrial function for the treatment of triple negative breast cancer: Development of a small molecule inhibitor against mitochondrial STAT3
    Kanchi, M. M.
    Hirpara, J. L.
    Sachaphibulkij, K.
    Tan, T. Z.
    Dietzel, H.
    Lim, L. H.
    Huang, R. Y-J
    Pervaiz, S.
    Neuzil, J.
    Kumar, A. P.
    [J]. CANCER RESEARCH, 2019, 79 (04)
  • [7] LNK promotes the growth and metastasis of triple negative breast cancer via activating JAK/STAT3 and ERK1/2 pathway
    Lv, Jianxin
    Yu, Wei
    Zhang, Yanan
    Cao, Xinhua
    Han, Lifei
    Hu, Haolin
    Wang, Chenfei
    [J]. CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [8] Osthole inhibits triple negative breast cancer cells by suppressing STAT3
    Dai, Xuanxuan
    Yin, Changtian
    Zhang, Yi
    Guo, Guilong
    Zhao, Chengguang
    Wang, Ouchen
    Xiang, Youqun
    Zhang, Xiaohua
    Liang, Guang
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2018, 37
  • [9] LNK promotes the growth and metastasis of triple negative breast cancer via activating JAK/STAT3 and ERK1/2 pathway
    Jianxin Lv
    Wei Yu
    Yanan Zhang
    Xinhua Cao
    Lifei Han
    Haolin Hu
    Chenfei Wang
    [J]. Cancer Cell International, 20
  • [10] Osthole inhibits triple negative breast cancer cells by suppressing STAT3
    Xuanxuan Dai
    Changtian Yin
    Yi Zhang
    Guilong Guo
    Chengguang Zhao
    Ouchen Wang
    Youqun Xiang
    Xiaohua Zhang
    Guang Liang
    [J]. Journal of Experimental & Clinical Cancer Research, 37
12345